U.S. Markets closed

How GlaxoSmithKline’s Pharmaceutical Business Performed

Mike Benson
How GlaxoSmithKline’s Pharmaceutical Business Performed

GlaxoSmithKline’s (GSK) Pharmaceutical segment includes various products from different therapeutic areas including respiratory products, HIV products, immuno-inflammation products, and established products. During the second quarter of 2018, the Pharmaceutical segment reported a 1% increase in operating revenues to ~4.23 billion pounds.